Novel Targeted Therapy for Neuroblastoma: Silencing the MXD3 Gene Using siRNA

BACKGROUND: Neuroblastoma is the second most common extracranial cancer in children. Current therapies for neuroblastoma, which use a combination of chemotherapy drugs, have limitations for high-risk subtypes and can cause significant long-term adverse effects in young patients. Therefore, a new the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Res
Main Authors: Duong, Connie, Yoshida, Sakiko, Chen, Cathy, Barisone, Gustavo, Diaz, Elva, Li, Yueju, Beckett, Laurel, Chung, Jong, Antony, Reuben, Nolta, Jan, Nitin, Nitin, Satake, Noriko
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5766270/
https://ncbi.nlm.nih.gov/pubmed/28419087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pr.2017.74
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados